New bone drug LYN101 enters first human tests for osteoporosis
Disease control
ENROLLING_BY_INVITATION
This early-stage study tests a new drug called LYN101 to see if it is safe and how the body processes it. First, healthy adults get a single dose. Then, postmenopausal women with low bone mass get multiple doses. The goal is to help control bone loss and prevent fractures, but th…
Phase: PHASE1 • Sponsor: Shanghai TTM-Bio Technology Co., Ltd • Aim: Disease control
Last updated May 05, 2026 11:56 UTC